Trial NCT02548962

View at ClinicalTrials.gov 
Org. Study IDs: PCYC-1138-CA
Secondary IDs: PCI-32765

Last trial update was posted on 2019-11-21

MeSH Interventions

Dexamethasone Ibrutinib Pomalidomide

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions


Stopping Reasons

After completing Phase 1, the Sponsor elected not to move forward with Phase 2.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID